Hematopoietic Stem Cell Dysfunction and Regeneration in Severe Infection
严重感染时造血干细胞功能障碍和再生
基本信息
- 批准号:10598451
- 负责人:
- 金额:$ 40.5万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2019
- 资助国家:美国
- 起止时间:2019-04-01 至 2025-03-31
- 项目状态:未结题
- 来源:
- 关键词:AcuteAntibiotic ResistanceBiologicalBloodBlood PlateletsBlood VesselsBone MarrowCellsCommunicable DiseasesDiseaseErythrocytesExhibitsFunctional disorderGoalsHealthHematopoiesisHematopoietic stem cellsHemostatic functionHospital MortalityHost DefenseImmuneImmune System DiseasesImmune systemImpaired cognitionImpairmentInfectionInflammationInflammatoryLifeModelingNatural regenerationOrgan failureOutcomePatientsPlayPositioning AttributeProcessProductionRecoveryResearchRoleSepsisShockStressSurvivorsSystemSystemic infectionTestingTick-Borne InfectionsTimeTissuesVaccinesVascular Diseasesacute infectionburden of illnessclinically significantimprovedimproved outcomeinsightmortalitymortality riskprogramsstem cell functiontissue regenerationvector-borne pathogen
项目摘要
Project Summary
Survivors of severe infection often exhibit prolonged immune dysfunction, physical and cognitive decline,
and significantly elevated risk of mortality. How to improve long-term outcomes of survivors of severe
infection is of major clinical significance and represents an important open question. Here, we will explore
the long-term impact of shock-like infection, using models of tick-born infection and sepsis, on hematopoietic
stem cell (HSC) function by asking: What are the long-term impacts of severe infection on hematopoiesis
and HSC function? Are HSCs primed to produce particular lineages? Can we protect HSCs in severe
disease to improve outcomes in survivors? How is the bone marrow microenvironment (or niche), where
HSCs reside, impacted by severe disease?
Sepsis is a severe systemic infection that causes vascular dysfunction and organ failure, and represents a
major cause of mortality in hospitals. Despite advances in understanding of sepsis pathophysiology,
treatments are limited, and mortality remains high. At the same time, antibiotic resistance, the spread of
vector born pathogens, and the lack of vaccines for emerging infections are important factors in the global
increase in infectious disease burden. As serious infections continue to emerge and rates of sepsis have
increased, so has the number of survivors. Here, we aim to understand the biological impact of severe,
acute infection on the function of HSCs and hematopoiesis during recovery, to provide new insight into the
decline in health after serious infection.
Continuous and balanced blood production relies on HSCs and progenitors and is essential for life. The
process of blood production generates cells of the immune system critical for host defense, as well as all
blood components necessary for oxygenation (red blood cells) and vascular hemostasis (platelets).
HSCs are positioned at the top of the blood system hierarchy, held in reserve, but can be activated by
acute inflammation to produce immune cells. What is unknown is how acute inflammatory insults impact
stem cell function in the long-term stages of recovery. In addition to immune cells, blood components
(RBCs and platelets) play underappreciated roles in host defense and are important for regeneration
and function of all tissue systems. Ultimately, we will test strategies to improve the number and function
of stem cells in survivors of severe infectious illness.
项目概要
严重感染的幸存者往往表现出长期的免疫功能障碍、身体和认知能力下降,
以及死亡风险显着升高。如何改善重症幸存者的长期结果
感染具有重要的临床意义,也是一个重要的悬而未决的问题。在这里,我们将探索
使用蜱传感染和败血症模型研究休克样感染对造血的长期影响
通过询问以下问题来了解干细胞 (HSC) 的功能:严重感染对造血功能的长期影响是什么
和HSC功能? HSC 是否准备好产生特定的谱系?在严重的情况下我们能保护HSC吗?
疾病以改善幸存者的结果?骨髓微环境(或生态位)如何,在哪里
HSC 存在,受到严重疾病的影响吗?
脓毒症是一种严重的全身感染,可导致血管功能障碍和器官衰竭,是一种严重的全身性感染。
医院死亡的主要原因。尽管对脓毒症病理生理学的理解取得了进展,
治疗方法有限,死亡率仍然很高。与此同时,抗生素耐药性的蔓延
媒介传播的病原体以及缺乏针对新发感染的疫苗是全球疫情的重要因素
传染病负担增加。随着严重感染的不断出现和败血症的发生率
增加了,幸存者的数量也增加了。在这里,我们的目标是了解严重的生物学影响,
急性感染对恢复期间 HSC 和造血功能的影响,为研究急性感染提供新的见解
严重感染后健康状况下降。
持续和平衡的血液生产依赖于造血干细胞和祖细胞,对生命至关重要。这
血液生产过程产生对宿主防御至关重要的免疫系统细胞,以及所有
氧合(红细胞)和血管止血(血小板)所需的血液成分。
HSC 位于血液系统层次结构的顶部,处于储备状态,但可以通过以下方式激活:
急性炎症产生免疫细胞。目前尚不清楚的是急性炎症损伤如何影响
干细胞在长期恢复阶段的功能。除了免疫细胞之外,还有血液成分
(红细胞和血小板)在宿主防御中发挥着未被充分认识的作用,并且对再生很重要
和所有组织系统的功能。最终,我们将测试改进数量和功能的策略
严重传染病幸存者的干细胞。
项目成果
期刊论文数量(4)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
Bone Marrow Harbors a Unique Population of Dendritic Cells with the Potential to Boost Neutrophil Formation upon Exposure to Fungal Antigen.
- DOI:10.3390/cells11010055
- 发表时间:2021-12-24
- 期刊:
- 影响因子:6
- 作者:Goedhart M;Slot E;Pascutti MF;Geerman S;Rademakers T;Nota B;Huveneers S;Buul JDV;MacNamara KC;Voermans C;Nolte MA
- 通讯作者:Nolte MA
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
KATHERINE C. MACNAMARA其他文献
KATHERINE C. MACNAMARA的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('KATHERINE C. MACNAMARA', 18)}}的其他基金
Improving Inflammation Resolution to Mitigate Acquired Bone Marrow Failure
改善炎症消退以减轻获得性骨髓衰竭
- 批准号:
10595109 - 财政年份:2023
- 资助金额:
$ 40.5万 - 项目类别:
Hematopoietic Stem Cell Dysfunction and Regeneration in Severe Infection
严重感染时造血干细胞功能障碍和再生
- 批准号:
10371061 - 财政年份:2019
- 资助金额:
$ 40.5万 - 项目类别:
Hematopoietic Stem Cell Dysfunction and Regeneration in Severe Infection
严重感染时造血干细胞功能障碍和再生
- 批准号:
9902469 - 财政年份:2019
- 资助金额:
$ 40.5万 - 项目类别:
Interferon gamma Regulation of CD4 T Cell Responses in Tuberculosis
干扰素 γ 对结核病中 CD4 T 细胞反应的调节
- 批准号:
7666156 - 财政年份:2008
- 资助金额:
$ 40.5万 - 项目类别:
Interferon gamma Regulation of CD4 T Cell Responses in Tuberculosis
干扰素 γ 对结核病中 CD4 T 细胞反应的调节
- 批准号:
7541020 - 财政年份:2008
- 资助金额:
$ 40.5万 - 项目类别:
相似海外基金
Ecological and Evolutionary Drivers of Antibiotic Resistance in Patients
患者抗生素耐药性的生态和进化驱动因素
- 批准号:
EP/Y031067/1 - 财政年份:2024
- 资助金额:
$ 40.5万 - 项目类别:
Research Grant
Collaborative Research: Leveraging the interactions between carbon nanomaterials and DNA molecules for mitigating antibiotic resistance
合作研究:利用碳纳米材料和 DNA 分子之间的相互作用来减轻抗生素耐药性
- 批准号:
2307222 - 财政年份:2024
- 资助金额:
$ 40.5万 - 项目类别:
Standard Grant
Collaborative Research: Leveraging the interactions between carbon nanomaterials and DNA molecules for mitigating antibiotic resistance
合作研究:利用碳纳米材料和 DNA 分子之间的相互作用来减轻抗生素耐药性
- 批准号:
2307223 - 财政年份:2024
- 资助金额:
$ 40.5万 - 项目类别:
Standard Grant
Molecular Epidemiology of Antibiotic Resistance in Clostridioides difficile
艰难梭菌抗生素耐药性的分子流行病学
- 批准号:
502587 - 财政年份:2024
- 资助金额:
$ 40.5万 - 项目类别:
The roles of a universally conserved DNA-and RNA-binding domain in controlling MRSA virulence and antibiotic resistance
普遍保守的 DNA 和 RNA 结合域在控制 MRSA 毒力和抗生素耐药性中的作用
- 批准号:
MR/Y013131/1 - 财政年份:2024
- 资助金额:
$ 40.5万 - 项目类别:
Research Grant
Determining structural dynamics of membrane proteins in their native environment: focus on bacterial antibiotic resistance
确定膜蛋白在其天然环境中的结构动力学:关注细菌抗生素耐药性
- 批准号:
MR/X009580/1 - 财政年份:2024
- 资助金额:
$ 40.5万 - 项目类别:
Fellowship
CAREER: Systems Microbiology and InterdiscipLinary Education for Halting Environmental Antibiotic Resistance Transmission (SMILE HEART)
职业:阻止环境抗生素耐药性传播的系统微生物学和跨学科教育(SMILE HEART)
- 批准号:
2340818 - 财政年份:2024
- 资助金额:
$ 40.5万 - 项目类别:
Continuing Grant
Reinforcing the battle at the bacterial cell wall: Structure-guided characterization and inhibition of beta-lactam antibiotic resistance signalling mechanisms
加强细菌细胞壁的战斗:β-内酰胺抗生素耐药信号机制的结构引导表征和抑制
- 批准号:
480022 - 财政年份:2023
- 资助金额:
$ 40.5万 - 项目类别:
Operating Grants
The spread of antibiotic resistance in bacteria-plasmid networks
抗生素耐药性在细菌-质粒网络中的传播
- 批准号:
BB/X010473/1 - 财政年份:2023
- 资助金额:
$ 40.5万 - 项目类别:
Fellowship
An RNA Nanosensor for the Diagnosis of Antibiotic Resistance in M. Tuberculosis
用于诊断结核分枝杆菌抗生素耐药性的 RNA 纳米传感器
- 批准号:
10670613 - 财政年份:2023
- 资助金额:
$ 40.5万 - 项目类别: